Atsena Therapeutics Announces Positive 6-month Data from Ongoing Phase I/II Clinical Trial of ATSN-101 in Patients with Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D (LCA1)
April 25, 2023 07:30 ET
|
Atsena Therapeutics
ATSN-101 demonstrated clinically meaningful improvements in vision at the highest dose with no drug-related serious adverse events 6 months post treatmentData presented at ARVO 2023 DURHAM, N.C.,...
Orphan Drugs Market Size to Grow by USD 477 Bn by 2032 | Oncology Segment Accounted to Hold a Significant Revenue Share
April 24, 2023 21:10 ET
|
Market.Us
New York, April 24, 2023 (GLOBE NEWSWIRE) -- The Orphan Drugs Market size accounted for USD 168 billion in 2022 and it will expand to USD 477 billion by 2032, growing at a CAGR of 11.3% during the...
1-Year Outcomes of Phase 3 Study for SB15, Proposed biosimilar to Eylea (aflibercept), Presented at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
April 24, 2023 18:30 ET
|
Samsung Bioepis
SB15 demonstrates comparable efficacy, safety, immunogenicity, and pharmacokinetics profiles to reference aflibercept up to Week 56Switching group had similar efficacy and safety compared to the...
Valitor Presents Preclinical Data on its Long-acting Anti-VEGF Biologic in Development for Durable Treatment of Wet AMD at the Association for Research in Vision and Ophthalmology Annual Meeting
April 24, 2023 18:00 ET
|
Valitor, Inc.
BERKELEY, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today announced new data from VLTR-557, its...
Pupillometer Market Predicted to Achieve USD 697.8 Mn Value by 2032 with North America as Dominant Region | Market.us Study
April 24, 2023 16:39 ET
|
Market.Us
New York, April 24, 2023 (GLOBE NEWSWIRE) -- The Pupillometer Market size is projected to surpass around USD 697.8 million by 2032, and it is poised to reach a registered CAGR of 7.1% from 2023 to...
LUMIBIRD: 8% GROWTH FOR THE FIRST QUARTER OF 2023
April 24, 2023 11:45 ET
|
Lumibird SA
Lannion, 24 April 2023 – 17:45 8% GROWTH FOR THE FIRST QUARTER OF 2023 The Lumibird Group (FR0000038242 - LBIRD), the European leader for laser technologies, recorded 8% growth in consolidated...
Ophthalmology Lasers Market to Perceive Prominent Growth of USD 3,478.03 Million by 2030, Size, Share, Trends, Demand, Growth Analysis and Competitive Forecast
April 24, 2023 08:27 ET
|
Data Bridge Market Research
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research has unveiled a new report called "Ophthalmology Market" which provides an in-depth exploration of growth strategies, drivers,...
Design Therapeutics to Present Preclinical Data on its GeneTAC™ Small Molecule, DT-168, for the Treatment of Fuchs Endothelial Corneal Dystrophy at ARVO 2023
April 24, 2023 06:30 ET
|
Design Therapeutics, Inc.
Treatment with DT-168 Eye Drops Reduced Nuclear Foci and Significantly Improved Mis-Splicing In Vitro Company On-track to Submit Investigational New Drug Application for DT-168 in the Second Half of...
Life Biosciences Presents Groundbreaking Data at ARVO Demonstrating Restoration of Visual Function in Nonhuman Primates
April 23, 2023 13:30 ET
|
Life Biosciences
BOSTON, April 23, 2023 (GLOBE NEWSWIRE) -- Life Biosciences (Life Bio), a biotechnology company advancing innovative cellular rejuvenation technologies to reverse diseases of aging and injury and...
Doheny Eye Institute Announces Upcoming Presentations at ARVO 2023 Annual Meeting
April 21, 2023 09:05 ET
|
Doheny Eye Institute
PASADENA, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that more than 30 of its scientists and...